Arvinas Inc. (ARVN) and Pfizer (PFE) Announce PROTAC Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breas

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Arvinas Inc. (ARVN) and Pfizer (PFE) Announce PROTAC Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breas
(NASDAQ: ARVN) Delayed: 7.58 +0.49 (6.91%)
Previous Close $7.09    52 Week High $ 
Open $7.08    52 Week Low $ 
Day High $7.78    P/E N/A 
Day Low $7.08    EPS $ 
Volume 858,474       

Pfizer Inc. (NYSE: PFE) Delayed: 26.21 +0.04 (0.15%)
Previous Close $26.17    52 Week High $37.39 
Open $26.29    52 Week Low $28.25 
Day High $26.49    P/E 15.88 
Day Low $26.11    EPS $1.65 
Volume 38,768,485